Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nucleic acid vaccines

F R Vogel1, N Sarver

  • 1Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.

Clinical Microbiology Reviews
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The immunogenicity of a cell-derived H7N1 split influenza virion vaccine in mice.

Scandinavian journal of immunology·2009
Same author

Human immunodeficiency virus and AIDS: insights from animal lentiviruses.

Journal of virology·2000
Same author

Improving vaccine performance with adjuvants.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648.

Human gene therapy·1999
Same author

New viral vectors for HIV vaccine delivery.

AIDS research and human retroviruses·1998
Same author

Adjuvants in perspective.

Developments in biological standardization·1998
Same journal

Diagnostic challenges in re-emerging rickettsioses: why current tools fall short.

Clinical microbiology reviews·2026
Same journal

Current progress in developing mRNA-lipid nanoparticle vaccines against human bacterial pathogens.

Clinical microbiology reviews·2026
Same journal

The gut microbiome and colorectal cancer.

Clinical microbiology reviews·2026
Same journal

Influence of fungi on epithelial homeostasis and role in inflammatory diseases.

Clinical microbiology reviews·2026
Same journal

Coxsackievirus A6 on the rise: epidemiology, pathogenicity, evolutionary dynamics, and antiviral strategy.

Clinical microbiology reviews·2026
Same journal

Intravesical therapies for catheter-associated urinary tract infections: current approaches and future directions.

Clinical microbiology reviews·2026
See all related articles

Nucleic acid vaccines mimic natural infection, generating strong immune responses. This novel immunization approach shows promise for safety and efficacy, offering advantages in delivery and expression.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Nucleic acid-based vaccines represent a novel immunization strategy.
  • They induce immune responses comparable to live, attenuated vaccines.

Purpose of the Study:

  • To evaluate the potential of nucleic acid vaccines.
  • To highlight their mechanism of action and advantages.

Main Methods:

  • Administration of nucleic acid vaccines leads to endogenous protein generation.
  • These proteins possess native conformation and posttranslational modifications.

Main Results:

  • Nucleic acid vaccines elicit both antibody and cytotoxic T-lymphocyte responses.
  • They demonstrate effectiveness against diverse protein antigens.

Related Experiment Videos

Conclusions:

  • Nucleic acid vaccines offer advantages such as vector simplicity, ease of delivery, and prolonged expression.
  • Further research is required to confirm their feasibility, safety, and efficacy.